BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12215865)

  • 1. Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy.
    Gür A; Denli A; Nas K; Cevik R; Karakoc M; Sarac AJ; Erdogan F
    Rheumatol Int; 2002 Sep; 22(5):194-8. PubMed ID: 12215865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of alendronate and calcitonin on cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study.
    Gür A; Denli A; Cevik R; Nas K; Karakoc M; Saraç AJ
    Yonsei Med J; 2003 Feb; 44(1):99-109. PubMed ID: 12619182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
    Shaarawy M; Zaki S; Sheiba M; El-Minawi AM
    Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
    Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
    Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between circulating tumor necrosis factor system and bone mass before and after estrogen plus progestogen therapy.
    Kim JG; Ku SY; Kim H; Chun SW; Suh CS; Choi YM
    Menopause; 2009; 16(3):534-8. PubMed ID: 19225428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis.
    Ralston SH
    J Bone Miner Res; 1994 Jun; 9(6):883-90. PubMed ID: 8079663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
    Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.
    Küpeli E; Karnak D; Beder S; Kayacan O; Tutkak H
    Respiration; 2008; 75(1):73-8. PubMed ID: 17975298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.
    Morabito N; Russo GT; Gaudio A; Lasco A; Catalano A; Morini E; Franchina F; Maisano D; La Rosa M; Plota M; Crifò A; Meo A; Frisina N
    Bone; 2007 Jun; 40(6):1588-94. PubMed ID: 17412659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.
    Gur A; Colpan L; Cevik R; Nas K; Jale Sarac A
    Clin Biochem; 2005 Jan; 38(1):66-72. PubMed ID: 15607319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
    Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
    Abiru S; Migita K; Maeda Y; Daikoku M; Ito M; Ohata K; Nagaoka S; Matsumoto T; Takii Y; Kusumoto K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
    Liver Int; 2006 Feb; 26(1):39-45. PubMed ID: 16420507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.
    Arican O; Aral M; Sasmaz S; Ciragil P
    Mediators Inflamm; 2005 Oct; 2005(5):273-9. PubMed ID: 16258194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of serum cytokine levels with axial bone mineral density.
    Sahin G; Ozturk C; Bagis S; Cimen OB; Erdogan C
    Singapore Med J; 2002 Nov; 43(11):576-8. PubMed ID: 12680527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.